MedPath
NMPA Approval

Rivaroxaban Granules

国药准字H20258003

January 8, 2025

国药准字H20243387

Drug Information

利伐沙班颗粒

颗粒剂

10mg

化学药品

January 8, 2025

Company Information

Applicant Company

江西省抚州市东乡区大富工业园区

Manufacturing Company

江西省抚州市东乡区大富工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班颗粒 - NMPA 批准文号 | MedPath